Anzeige
Meldung des Tages: Game Changer! Steht hier jetzt die strukturelle Neubewertung nach einem Strategiewechsel bevor?

Jazz Pharmaceuticals Aktie News

Aktie
WKN:  A1JS1K ISIN:  IE00B4Q5ZN47 US-Symbol:  JAZZ Branche:  Biotechnologie Land:  Irland
139,20 €
-1,35 €
-0,96%
08:01:23 Uhr
Depot/Watchlist
Marktkapitalisierung *
8,78 Mrd. €
Streubesitz
-
KGV
-
neu: Nachhaltigkeits-Score
37 %
Index-Zuordnung
-
Weiter abwärts? Short handeln - Jetzt mit Hebel 9,85: JV6UAS
Werbung

Jazz Pharmaceuticals News

30.04.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference PR Newswire
30.04.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference PR Newswire
25.04.25 - PR Newswire
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer PR Newswire
23.04.25 - PR Newswire
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma PR ...
22.04.25 - PR Newswire
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 PR Newswire
22.04.25 - PR Newswire
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 PR Newswire
21.04.25 - PR Newswire
Jazz Pharmaceuticals Completes Acquisition of Chimerix
Jazz Pharmaceuticals Completes Acquisition of Chimerix PR Newswire
21.04.25 - PR Newswire
Jazz Pharmaceuticals Completes Acquisition of Chimerix
Jazz Pharmaceuticals Completes Acquisition of Chimerix PR Newswire
26.03.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
26.03.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
19.03.25 - PR Newswire
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® ...
10.03.25 - LYNX Analysen
Jazz Pharmaceuticals mit Rückenwind
Das irische Pharmaunternehmen trotzt der allgemein schwachen Entwicklung der Wall Street und zeigt seit geraumer Zeit Relative Stärke gegenüber dem Gesamtmarkt. Jetzt ...
05.03.25 - PR Newswire
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio PR Newswire
05.03.25 - PR Newswire
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio PR Newswire
25.02.25 - PR Newswire
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance PR Newswire
25.02.25 - PR Newswire
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance PR Newswire
20.02.25 - PR Newswire
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference PR Newswire
20.02.25 - PR Newswire
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference PR Newswire
11.02.25 - PR Newswire
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 PR Newswire

Newssuche

Videos

newspaper
01:40 Uhr -0,04%
Wahnsinn! Warum Daytrader im FDAX oft verlieren
Ab Montag, dem 2. Februar börsentäglich ab 18 Uhr - FEIERABEND-​TRADING! Echte Trades auf Basis ... Mehr »